Xylem (NYSE: XYL) reported Q2 EPS of $0.66, $0.04 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.31 billion.

GUIDANCE:

Raises full-year organic revenue guidance to a range of 6% to 8%, and raises mid-point of earnings per share guidance

For earnings history and earnings-related data on Xylem (XYL) click here.